Two Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase 1 Studies Evaluating BTH1677, a 1, 3–1,6 Beta Glucan Pathogen Associated Molecular Pattern, in Healthy Volunteer Subjects